Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Who lowered the bar?
View:
Post by sunshine7 on Mar 22, 2016 4:23pm

Who lowered the bar?

Found these on WSJ site. Seems the targets were adjusted down by the analysts over the past few months. Is this a set up? NOTE: all in CD
Q4 2015 Estimate Trends
Current: $1.76
1 month ago: $2.10
3 months ago: $1.99

Q1 2016 Estimate Trends
Current: $1.97
1 month ago: $2.22
3 months ago: $2.73
Comment by sunshine7 on Mar 23, 2016 11:08am
On my TD report it gives an average earnings estimate of $1.30 ($1.17-$1.52). Remember earnings are AFTER interest and taxes. Anything in this range is a positive as it shows the ability to pay off debt as per obligations plus reserve to accelerate payments and/or grow through product acquisitions. Look for slight earnings surprise up and increase in 2016 guidance.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities